Monday, February 2, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Chemicals

A Stunning Reversal for Dow Inc Shares

Felix Baarz by Felix Baarz
October 27, 2025
in Chemicals, Dow Jones, Earnings, Turnaround
0
Dow Stock
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

What transforms a stock that has plummeted over 35% since the start of the year into a sudden top performer? Dow Inc provided a surprising answer last week. The market celebrated the chemical giant with a 13% surge, even as the company reported declining revenues and a quarterly loss. Evidently, investors are seeing value beyond the stark headline figures.

Decoding the Market’s Reaction

The apparent contradiction between weak fundamentals and a powerful share price advance becomes clearer upon a detailed examination. While third-quarter revenue did fall by 8% to $10 billion, resulting in a loss of $0.19 per share, the company’s operating profit before interest and taxes (EBIT) showed remarkable improvement. It increased by a substantial $201 million compared to the previous quarter.

This impressive operational turnaround can be attributed to several key developments:
* Initial successes from aggressive cost-reduction initiatives are materializing.
* New production facilities along the U.S. Gulf Coast are ramping up more effectively than anticipated.
* Reduced maintenance expenses are providing relief to the balance sheet.
* Key business segments are reporting volume growth.

Should investors sell immediately? Or is it worth buying Dow?

Lingering Caution Among Market Experts

Despite the positive momentum that pushed the stock to a Friday close of $24.80—placing it 15% above its 50-day moving average—analysts maintain a cautious stance. The prevailing consensus recommendation remains “Hold,” with an average price target of $26.93. This suggests a potential upside of just 8% from current levels.

A particularly telling statistic is that, even after this recent recovery, Dow shares continue to trade 47% below their 52-week high, recorded in October 2024. Looking ahead, market observers still project negative earnings for 2025, albeit at a less severe level.

The critical question now is whether Dow can leverage this positive impulse and definitively leave its lows behind. Or is this merely a temporary rebound within a persistent downward trend? The answer hinges on the company’s ability to prove that its cost-saving measures can durably offset the ongoing weak demand plaguing the chemical industry.

Ad

Dow Stock: Buy or Sell?! New Dow Analysis from February 2 delivers the answer:

The latest Dow figures speak for themselves: Urgent action needed for Dow investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 2.

Dow: Buy or sell? Read more here...

Tags: DOW
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Bloom Energy Stock
Earnings

Bloom Energy’s Billion-Dollar Deals Signal Strategic Shift

February 2, 2026
iRobot Stock
Mergers & Acquisitions

iRobot Exits Public Markets Following Acquisition and Restructuring

February 2, 2026
AMD Stock
AI & Quantum Computing

AMD’s Pivotal Earnings Report: A Test of AI Ambitions

February 2, 2026
Next Post
Union Pacific Stock

Wall Street Reassesses Union Pacific Following Mixed Quarterly Results

Applied Materials Stock

Applied Materials Faces Strategic Crossroads Amid Export Restrictions

Arrowhead Stock

Novartis Forges Multi-Billion Dollar Partnership with Arrowhead Pharmaceuticals

Recommended

Beyond Meat Stock

Beyond Meat Shares Plummet as Earnings Delay Sparks Investor Panic

3 months ago
Pharmaceutical Stock Market Today

FDA Approves Special Protocol Assessment for Outlook Therapeutics NORSE EIGHT Trial

2 years ago
Microvast Holdings Stock

Microvast Shares Surge Following Capital Raise Announcement and Bullish Analyst Outlook

4 months ago
Healthcare cloud based

Wedbush Analyst Maintains Neutral Rating on Regenxbio with 21 Price Target

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Oracle’s High-Stakes Bet: A $50 Billion AI Gamble Amid Workforce Cuts

Sanofi’s Acquisition of Dynavax Nears Final Approval

AMD’s Pivotal Earnings Report: A Test of AI Ambitions

T1 Energy Shares Face Intense Scrutiny Amid Conflicting Signals

MercadoLibre Faces Supreme Court Showdown Amid Intensifying Rivalry

OMV’s 2025 Financial Report: Navigating Impairments and Strategic Shifts

Trending

Bitcoin Stock
Bitcoin

Bitcoin Faces Mounting Pressure Amid Policy Shifts

by Felix Baarz
February 2, 2026
0

The new trading week opened with significant headwinds for Bitcoin, as external macroeconomic and political developments overshadowed...

Bloom Energy Stock

Bloom Energy’s Billion-Dollar Deals Signal Strategic Shift

February 2, 2026
iRobot Stock

iRobot Exits Public Markets Following Acquisition and Restructuring

February 2, 2026
Oracle Stock

Oracle’s High-Stakes Bet: A $50 Billion AI Gamble Amid Workforce Cuts

February 2, 2026
Dynavax Stock

Sanofi’s Acquisition of Dynavax Nears Final Approval

February 2, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Bitcoin Faces Mounting Pressure Amid Policy Shifts
  • Bloom Energy’s Billion-Dollar Deals Signal Strategic Shift
  • iRobot Exits Public Markets Following Acquisition and Restructuring

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com